Global Surgical Site Infection Market Overview

The Surgical Site Infection Market size is expected to grow from USD 4.59 Billion in 2022 to USD 6.38 Billion by 2030, at a CAGR of 4.2% during the forecast period.

When an infection develops in the area of the body where surgery was performed, it is called a surgical site infection. Sometimes infections at surgical sites are only skin deep. Infections at other surgical sites can be much more dangerous because they can spread to deeper layers of tissue, organs, or implanted materials. The Centers for Disease Control and Prevention (CDC) publishes guidelines and tools for the medical community to help eliminate surgical site infections, and it also provides resources for the general public to learn more about these infections and take preventative measures. Patients who have recently undergone surgery are at increased risk for developing an infection at the incision site, which can lead to a number of complications and even a second hospitalization. One of the primary causes of surgical site infections is pathogenic wound contamination during surgical procedures, while another primary cause is a compromised immune system's inability to fight off bacterial invaders.

Surgery-related infections are just one source of surgical site infections; factors like patient obesity, smoking, cancer, diabetes, and a compromised immune system also play a role. Infections at surgical sites can be classified as either superficial (in the skin), deep (in the muscle), or space (in the surrounding tissue) by the CDC.

Market Dynamics and Factors for Surgical Site Infection Market

Drivers:

• Rising Incidence of Surgical Site Infection.

Restraints:

• Lack of Awareness of Protective Measures

Opportunity:

• Opportunities in the Growing Number of Surgeries

Challenges:

• The Implementation of New Standards of Care

Regional Analysis in Surgical Site Infection Market

The market for medicines to prevent and treat infections at surgical sites can be broken down into regional subsets. APAC, LATA, and MEA are the regions in question. The developed healthcare infrastructure in North America and Europe, as well as rising investments in research activities by many key players in developing innovative treatments of surgical site infection, are expected to keep these regions at the forefront of the global surgical site infections treatment market over the forecast period. North America's surgical site infections treatment market is expected to grow at a significant rate due to the region's large patient pool, growing awareness from government organizations, and rising prevalence of surgical site infections. The markets in Latin America and the Middle East and Africa are also expected to expand, but for different reasons.

Covid-19 Impact Analysis on Surgical Site Infection Market

As a result of hospitals and clinics postponing surgical procedures to avoid the spread of the COVID-19 virus, the global COVID-19 outbreak and the lockdown scenario in certain countries have caused hurdles for the surgical equipment business. Surgical procedures were affected by the spread of COVID-19. The number of surgeries performed during the pandemic dropped dramatically as a result of the regulatory authorities' strict guidance against performing any non-emergency surgeries. For instance, worldwide admissions for general surgery fell by 42.8% in the study published in October 2021 by the National Library of Medicine. As a result, the COVID-19 pandemic had a major effect on the market for preventing infections at surgical sites. The wide spread of COVID-19, however, drove home the importance of practicing good hand hygiene and employing other traditional forms of infection control. In addition, the market quickly recovered to pre-pandemic levels as elective surgeries resumed and COVID-19 cases leveled off. Sani-24 Germicidal Disposable Wipe, Sani-HyPerCide Germicidal Disposable Wipe, and Sani-HyPerCide Germicidal Spray were all introduced by PDI in March 2022 to aid infection preventionists in their fight against the spread of HAIs and COVID-19.

Top Key Players Covered in Surgical Site Infection Market

• 3M Company (U.S)
• STERIS plc (U.K)
• Stryker Corporation (U.S)
• Medtronic plc (Ireland)
• Prescient Surgical Inc. (U.S)
• Covalon Technologies Ltd. (Canada)
• Surgical Site Infection Prevention LLC (U.S)
• HARTMANN GROUP (Germany)
• Mölnlycke Health Care AB (Sweden)
• Becton (U.S)
• Dickinson and Company (U.S), and Other Major Players

Key Industry Development in The Surgical Site Infection Market

In May 2019, KCI Licensing, Inc. received FDA approval to use PREVENA negative pressure incision system to reduce superficial surgical site infections in patients at high risk of post-op infections.

In October 2018, 3M Company launched SoluPrep Film-Forming Sterile Surgical Solution. The company stated that that the new surgical infection control product is a 2% chlorhexidine gluconate and 7055 isopropyl alc surgical skin preparation solution.

Chapter 1: Introduction
 1.1 Research Objectives
 1.2 Research Methodology
 1.3 Research Process
 1.4 Scope and Coverage
  1.4.1 Market Definition
  1.4.2 Key Questions Answered
 1.5 Market Segmentation

Chapter 2:Executive Summary

Chapter 3:Growth Opportunities By Segment
 3.1 By Product
 3.2 By Type
 3.3 By Phase
 3.4 By End-Users

Chapter 4: Market Landscape
 4.1 Porter's Five Forces Analysis
  4.1.1 Bargaining Power of Supplier
  4.1.2 Threat of New Entrants
  4.1.3 Threat of Substitutes
  4.1.4 Competitive Rivalry
  4.1.5 Bargaining Power Among Buyers
 4.2 Industry Value Chain Analysis
 4.3 Market Dynamics
  4.3.1 Drivers
  4.3.2 Restraints
  4.3.3 Opportunities
  4.5.4 Challenges
 4.4 Pestle Analysis
 4.5 Technological Roadmap
 4.6 Regulatory Landscape
 4.7 SWOT Analysis
 4.8 Price Trend Analysis
 4.9 Patent Analysis
 4.10 Analysis of the Impact of Covid-19
  4.10.1 Impact on the Overall Market
  4.10.2 Impact on the Supply Chain
  4.10.3 Impact on the Key Manufacturers
  4.10.4 Impact on the Pricing

Chapter 5: Surgical Site Infection Market by Product
 5.1 Surgical Site Infection Market Overview Snapshot and Growth Engine
 5.2 Surgical Site Infection Market Overview
 5.3 Wound Care Dressing
  5.3.1 Introduction and Market Overview
  5.3.2 Historic and Forecasted Market Size (2016-2028F)
  5.3.3 Key Market Trends, Growth Factors and Opportunities
  5.3.4 Wound Care Dressing: Geographic Segmentation
 5.4 Antibiotic Prophylaxis Products
  5.4.1 Introduction and Market Overview
  5.4.2 Historic and Forecasted Market Size (2016-2028F)
  5.4.3 Key Market Trends, Growth Factors and Opportunities
  5.4.4 Antibiotic Prophylaxis Products: Geographic Segmentation
 5.5 Antiseptics and Disinfectants
  5.5.1 Introduction and Market Overview
  5.5.2 Historic and Forecasted Market Size (2016-2028F)
  5.5.3 Key Market Trends, Growth Factors and Opportunities
  5.5.4 Antiseptics and Disinfectants: Geographic Segmentation
 5.6 Surgical Drapers
  5.6.1 Introduction and Market Overview
  5.6.2 Historic and Forecasted Market Size (2016-2028F)
  5.6.3 Key Market Trends, Growth Factors and Opportunities
  5.6.4 Surgical Drapers: Geographic Segmentation
 5.7 Others
  5.7.1 Introduction and Market Overview
  5.7.2 Historic and Forecasted Market Size (2016-2028F)
  5.7.3 Key Market Trends, Growth Factors and Opportunities
  5.7.4 Others: Geographic Segmentation

Chapter 6: Surgical Site Infection Market by Type
 6.1 Surgical Site Infection Market Overview Snapshot and Growth Engine
 6.2 Surgical Site Infection Market Overview
 6.3 Superficial Incisional Infection
  6.3.1 Introduction and Market Overview
  6.3.2 Historic and Forecasted Market Size (2016-2028F)
  6.3.3 Key Market Trends, Growth Factors and Opportunities
  6.3.4 Superficial Incisional Infection: Geographic Segmentation
 6.4 Deep Incisional Infection
  6.4.1 Introduction and Market Overview
  6.4.2 Historic and Forecasted Market Size (2016-2028F)
  6.4.3 Key Market Trends, Growth Factors and Opportunities
  6.4.4 Deep Incisional Infection: Geographic Segmentation
 6.5 Space Infection
  6.5.1 Introduction and Market Overview
  6.5.2 Historic and Forecasted Market Size (2016-2028F)
  6.5.3 Key Market Trends, Growth Factors and Opportunities
  6.5.4 Space Infection: Geographic Segmentation

Chapter 7: Surgical Site Infection Market by Phase
 7.1 Surgical Site Infection Market Overview Snapshot and Growth Engine
 7.2 Surgical Site Infection Market Overview
 7.3 Preoperative Phase
  7.3.1 Introduction and Market Overview
  7.3.2 Historic and Forecasted Market Size (2016-2028F)
  7.3.3 Key Market Trends, Growth Factors and Opportunities
  7.3.4 Preoperative Phase: Geographic Segmentation
 7.4 Intraoperative Phase
  7.4.1 Introduction and Market Overview
  7.4.2 Historic and Forecasted Market Size (2016-2028F)
  7.4.3 Key Market Trends, Growth Factors and Opportunities
  7.4.4 Intraoperative Phase: Geographic Segmentation
 7.5 Postoperative Phase
  7.5.1 Introduction and Market Overview
  7.5.2 Historic and Forecasted Market Size (2016-2028F)
  7.5.3 Key Market Trends, Growth Factors and Opportunities
  7.5.4 Postoperative Phase: Geographic Segmentation

Chapter 8: Surgical Site Infection Market by End-Users
 8.1 Surgical Site Infection Market Overview Snapshot and Growth Engine
 8.2 Surgical Site Infection Market Overview
 8.3 Hospitals
  8.3.1 Introduction and Market Overview
  8.3.2 Historic and Forecasted Market Size (2016-2028F)
  8.3.3 Key Market Trends, Growth Factors and Opportunities
  8.3.4 Hospitals: Geographic Segmentation
 8.4 Clinics
  8.4.1 Introduction and Market Overview
  8.4.2 Historic and Forecasted Market Size (2016-2028F)
  8.4.3 Key Market Trends, Growth Factors and Opportunities
  8.4.4 Clinics: Geographic Segmentation
 8.5 Ambulatory Surgery Centers
  8.5.1 Introduction and Market Overview
  8.5.2 Historic and Forecasted Market Size (2016-2028F)
  8.5.3 Key Market Trends, Growth Factors and Opportunities
  8.5.4 Ambulatory Surgery Centers: Geographic Segmentation
 8.6 Others
  8.6.1 Introduction and Market Overview
  8.6.2 Historic and Forecasted Market Size (2016-2028F)
  8.6.3 Key Market Trends, Growth Factors and Opportunities
  8.6.4 Others: Geographic Segmentation

Chapter 9: Company Profiles and Competitive Analysis
 9.1 Competitive Landscape
  9.1.1 Competitive Positioning
  9.1.2 Surgical Site Infection Sales and Market Share By Players
  9.1.3 Industry BCG Matrix
  9.1.4 Heat Map Analysis
  9.1.5 Surgical Site Infection Industry Concentration Ratio (CR5 and HHI)
  9.1.6 Top 5 Surgical Site Infection Players Market Share
  9.1.7 Mergers and Acquisitions
  9.1.8 Business Strategies By Top Players
 9.2 3M COMPANY
  9.2.1 Company Overview
  9.2.2 Key Executives
  9.2.3 Company Snapshot
  9.2.4 Operating Business Segments
  9.2.5 Product Portfolio
  9.2.6 Business Performance
  9.2.7 Key Strategic Moves and Recent Developments
  9.2.8 SWOT Analysis
 9.3 STERIS PLC
 9.4 STRYKER CORPORATION
 9.5 MEDTRONIC PLC
 9.6 PRESCIENT SURGICAL INC.
 9.7 COVALON TECHNOLOGIES LTD.
 9.8 SURGICAL SITE INFECTION PREVENTION LLC
 9.9 HARTMANN GROUP
 9.10 MÖLNLYCKE HEALTH CARE AB
 9.11 BECTON
 9.12 DICKINSON AND COMPANY
 9.13 OTHER MAJOR PLAYERS

Chapter 10: Global Surgical Site Infection Market Analysis, Insights and Forecast, 2016-2028
 10.1 Market Overview
 10.2 Historic and Forecasted Market Size By Product
  10.2.1 Wound Care Dressing
  10.2.2 Antibiotic Prophylaxis Products
  10.2.3 Antiseptics and Disinfectants
  10.2.4 Surgical Drapers
  10.2.5 Others
 10.3 Historic and Forecasted Market Size By Type
  10.3.1 Superficial Incisional Infection
  10.3.2 Deep Incisional Infection
  10.3.3 Space Infection
 10.4 Historic and Forecasted Market Size By Phase
  10.4.1 Preoperative Phase
  10.4.2 Intraoperative Phase
  10.4.3 Postoperative Phase
 10.5 Historic and Forecasted Market Size By End-Users
  10.5.1 Hospitals
  10.5.2 Clinics
  10.5.3 Ambulatory Surgery Centers
  10.5.4 Others

Chapter 11: North America Surgical Site Infection Market Analysis, Insights and Forecast, 2016-2028
 11.1 Key Market Trends, Growth Factors and Opportunities
 11.2 Impact of Covid-19
 11.3 Key Players
 11.4 Key Market Trends, Growth Factors and Opportunities
 11.4 Historic and Forecasted Market Size By Product
  11.4.1 Wound Care Dressing
  11.4.2 Antibiotic Prophylaxis Products
  11.4.3 Antiseptics and Disinfectants
  11.4.4 Surgical Drapers
  11.4.5 Others
 11.5 Historic and Forecasted Market Size By Type
  11.5.1 Superficial Incisional Infection
  11.5.2 Deep Incisional Infection
  11.5.3 Space Infection
 11.6 Historic and Forecasted Market Size By Phase
  11.6.1 Preoperative Phase
  11.6.2 Intraoperative Phase
  11.6.3 Postoperative Phase
 11.7 Historic and Forecasted Market Size By End-Users
  11.7.1 Hospitals
  11.7.2 Clinics
  11.7.3 Ambulatory Surgery Centers
  11.7.4 Others
 11.8 Historic and Forecast Market Size by Country
  11.8.1 U.S.
  11.8.2 Canada
  11.8.3 Mexico

Chapter 12: Europe Surgical Site Infection Market Analysis, Insights and Forecast, 2016-2028
 12.1 Key Market Trends, Growth Factors and Opportunities
 12.2 Impact of Covid-19
 12.3 Key Players
 12.4 Key Market Trends, Growth Factors and Opportunities
 12.4 Historic and Forecasted Market Size By Product
  12.4.1 Wound Care Dressing
  12.4.2 Antibiotic Prophylaxis Products
  12.4.3 Antiseptics and Disinfectants
  12.4.4 Surgical Drapers
  12.4.5 Others
 12.5 Historic and Forecasted Market Size By Type
  12.5.1 Superficial Incisional Infection
  12.5.2 Deep Incisional Infection
  12.5.3 Space Infection
 12.6 Historic and Forecasted Market Size By Phase
  12.6.1 Preoperative Phase
  12.6.2 Intraoperative Phase
  12.6.3 Postoperative Phase
 12.7 Historic and Forecasted Market Size By End-Users
  12.7.1 Hospitals
  12.7.2 Clinics
  12.7.3 Ambulatory Surgery Centers
  12.7.4 Others
 12.8 Historic and Forecast Market Size by Country
  12.8.1 Germany
  12.8.2 U.K.
  12.8.3 France
  12.8.4 Italy
  12.8.5 Russia
  12.8.6 Spain
  12.8.7 Rest of Europe

Chapter 13: Asia-Pacific Surgical Site Infection Market Analysis, Insights and Forecast, 2016-2028
 13.1 Key Market Trends, Growth Factors and Opportunities
 13.2 Impact of Covid-19
 13.3 Key Players
 13.4 Key Market Trends, Growth Factors and Opportunities
 13.4 Historic and Forecasted Market Size By Product
  13.4.1 Wound Care Dressing
  13.4.2 Antibiotic Prophylaxis Products
  13.4.3 Antiseptics and Disinfectants
  13.4.4 Surgical Drapers
  13.4.5 Others
 13.5 Historic and Forecasted Market Size By Type
  13.5.1 Superficial Incisional Infection
  13.5.2 Deep Incisional Infection
  13.5.3 Space Infection
 13.6 Historic and Forecasted Market Size By Phase
  13.6.1 Preoperative Phase
  13.6.2 Intraoperative Phase
  13.6.3 Postoperative Phase
 13.7 Historic and Forecasted Market Size By End-Users
  13.7.1 Hospitals
  13.7.2 Clinics
  13.7.3 Ambulatory Surgery Centers
  13.7.4 Others
 13.8 Historic and Forecast Market Size by Country
  13.8.1 China
  13.8.2 India
  13.8.3 Japan
  13.8.4 Singapore
  13.8.5 Australia
  13.8.6 New Zealand
  13.8.7 Rest of APAC

Chapter 14: Middle East & Africa Surgical Site Infection Market Analysis, Insights and Forecast, 2016-2028
 14.1 Key Market Trends, Growth Factors and Opportunities
 14.2 Impact of Covid-19
 14.3 Key Players
 14.4 Key Market Trends, Growth Factors and Opportunities
 14.4 Historic and Forecasted Market Size By Product
  14.4.1 Wound Care Dressing
  14.4.2 Antibiotic Prophylaxis Products
  14.4.3 Antiseptics and Disinfectants
  14.4.4 Surgical Drapers
  14.4.5 Others
 14.5 Historic and Forecasted Market Size By Type
  14.5.1 Superficial Incisional Infection
  14.5.2 Deep Incisional Infection
  14.5.3 Space Infection
 14.6 Historic and Forecasted Market Size By Phase
  14.6.1 Preoperative Phase
  14.6.2 Intraoperative Phase
  14.6.3 Postoperative Phase
 14.7 Historic and Forecasted Market Size By End-Users
  14.7.1 Hospitals
  14.7.2 Clinics
  14.7.3 Ambulatory Surgery Centers
  14.7.4 Others
 14.8 Historic and Forecast Market Size by Country
  14.8.1 Turkey
  14.8.2 Saudi Arabia
  14.8.3 Iran
  14.8.4 UAE
  14.8.5 Africa
  14.8.6 Rest of MEA

Chapter 15: South America Surgical Site Infection Market Analysis, Insights and Forecast, 2016-2028
 15.1 Key Market Trends, Growth Factors and Opportunities
 15.2 Impact of Covid-19
 15.3 Key Players
 15.4 Key Market Trends, Growth Factors and Opportunities
 15.4 Historic and Forecasted Market Size By Product
  15.4.1 Wound Care Dressing
  15.4.2 Antibiotic Prophylaxis Products
  15.4.3 Antiseptics and Disinfectants
  15.4.4 Surgical Drapers
  15.4.5 Others
 15.5 Historic and Forecasted Market Size By Type
  15.5.1 Superficial Incisional Infection
  15.5.2 Deep Incisional Infection
  15.5.3 Space Infection
 15.6 Historic and Forecasted Market Size By Phase
  15.6.1 Preoperative Phase
  15.6.2 Intraoperative Phase
  15.6.3 Postoperative Phase
 15.7 Historic and Forecasted Market Size By End-Users
  15.7.1 Hospitals
  15.7.2 Clinics
  15.7.3 Ambulatory Surgery Centers
  15.7.4 Others
 15.8 Historic and Forecast Market Size by Country
  15.8.1 Brazil
  15.8.2 Argentina
  15.8.3 Rest of SA

Chapter 16 Investment Analysis

Chapter 17 Analyst Viewpoint and Conclusion

LIST OF TABLES

TABLE 001. EXECUTIVE SUMMARY
TABLE 002. SURGICAL SITE INFECTION MARKET BARGAINING POWER OF SUPPLIERS
TABLE 003. SURGICAL SITE INFECTION MARKET BARGAINING POWER OF CUSTOMERS
TABLE 004. SURGICAL SITE INFECTION MARKET COMPETITIVE RIVALRY
TABLE 005. SURGICAL SITE INFECTION MARKET THREAT OF NEW ENTRANTS
TABLE 006. SURGICAL SITE INFECTION MARKET THREAT OF SUBSTITUTES
TABLE 007. SURGICAL SITE INFECTION MARKET BY PRODUCT
TABLE 008. WOUND CARE DRESSING MARKET OVERVIEW (2016-2028)
TABLE 009. ANTIBIOTIC PROPHYLAXIS PRODUCTS MARKET OVERVIEW (2016-2028)
TABLE 010. ANTISEPTICS AND DISINFECTANTS MARKET OVERVIEW (2016-2028)
TABLE 011. SURGICAL DRAPERS MARKET OVERVIEW (2016-2028)
TABLE 012. OTHERS MARKET OVERVIEW (2016-2028)
TABLE 013. SURGICAL SITE INFECTION MARKET BY TYPE
TABLE 014. SUPERFICIAL INCISIONAL INFECTION MARKET OVERVIEW (2016-2028)
TABLE 015. DEEP INCISIONAL INFECTION MARKET OVERVIEW (2016-2028)
TABLE 016. SPACE INFECTION MARKET OVERVIEW (2016-2028)
TABLE 017. SURGICAL SITE INFECTION MARKET BY PHASE
TABLE 018. PREOPERATIVE PHASE MARKET OVERVIEW (2016-2028)
TABLE 019. INTRAOPERATIVE PHASE MARKET OVERVIEW (2016-2028)
TABLE 020. POSTOPERATIVE PHASE MARKET OVERVIEW (2016-2028)
TABLE 021. SURGICAL SITE INFECTION MARKET BY END-USERS
TABLE 022. HOSPITALS MARKET OVERVIEW (2016-2028)
TABLE 023. CLINICS MARKET OVERVIEW (2016-2028)
TABLE 024. AMBULATORY SURGERY CENTERS MARKET OVERVIEW (2016-2028)
TABLE 025. OTHERS MARKET OVERVIEW (2016-2028)
TABLE 026. NORTH AMERICA SURGICAL SITE INFECTION MARKET, BY PRODUCT (2016-2028)
TABLE 027. NORTH AMERICA SURGICAL SITE INFECTION MARKET, BY TYPE (2016-2028)
TABLE 028. NORTH AMERICA SURGICAL SITE INFECTION MARKET, BY PHASE (2016-2028)
TABLE 029. NORTH AMERICA SURGICAL SITE INFECTION MARKET, BY END-USERS (2016-2028)
TABLE 030. N SURGICAL SITE INFECTION MARKET, BY COUNTRY (2016-2028)
TABLE 031. EUROPE SURGICAL SITE INFECTION MARKET, BY PRODUCT (2016-2028)
TABLE 032. EUROPE SURGICAL SITE INFECTION MARKET, BY TYPE (2016-2028)
TABLE 033. EUROPE SURGICAL SITE INFECTION MARKET, BY PHASE (2016-2028)
TABLE 034. EUROPE SURGICAL SITE INFECTION MARKET, BY END-USERS (2016-2028)
TABLE 035. SURGICAL SITE INFECTION MARKET, BY COUNTRY (2016-2028)
TABLE 036. ASIA PACIFIC SURGICAL SITE INFECTION MARKET, BY PRODUCT (2016-2028)
TABLE 037. ASIA PACIFIC SURGICAL SITE INFECTION MARKET, BY TYPE (2016-2028)
TABLE 038. ASIA PACIFIC SURGICAL SITE INFECTION MARKET, BY PHASE (2016-2028)
TABLE 039. ASIA PACIFIC SURGICAL SITE INFECTION MARKET, BY END-USERS (2016-2028)
TABLE 040. SURGICAL SITE INFECTION MARKET, BY COUNTRY (2016-2028)
TABLE 041. MIDDLE EAST & AFRICA SURGICAL SITE INFECTION MARKET, BY PRODUCT (2016-2028)
TABLE 042. MIDDLE EAST & AFRICA SURGICAL SITE INFECTION MARKET, BY TYPE (2016-2028)
TABLE 043. MIDDLE EAST & AFRICA SURGICAL SITE INFECTION MARKET, BY PHASE (2016-2028)
TABLE 044. MIDDLE EAST & AFRICA SURGICAL SITE INFECTION MARKET, BY END-USERS (2016-2028)
TABLE 045. SURGICAL SITE INFECTION MARKET, BY COUNTRY (2016-2028)
TABLE 046. SOUTH AMERICA SURGICAL SITE INFECTION MARKET, BY PRODUCT (2016-2028)
TABLE 047. SOUTH AMERICA SURGICAL SITE INFECTION MARKET, BY TYPE (2016-2028)
TABLE 048. SOUTH AMERICA SURGICAL SITE INFECTION MARKET, BY PHASE (2016-2028)
TABLE 049. SOUTH AMERICA SURGICAL SITE INFECTION MARKET, BY END-USERS (2016-2028)
TABLE 050. SURGICAL SITE INFECTION MARKET, BY COUNTRY (2016-2028)
TABLE 051. 3M COMPANY: SNAPSHOT
TABLE 052. 3M COMPANY: BUSINESS PERFORMANCE
TABLE 053. 3M COMPANY: PRODUCT PORTFOLIO
TABLE 054. 3M COMPANY: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 054. STERIS PLC: SNAPSHOT
TABLE 055. STERIS PLC: BUSINESS PERFORMANCE
TABLE 056. STERIS PLC: PRODUCT PORTFOLIO
TABLE 057. STERIS PLC: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 057. STRYKER CORPORATION: SNAPSHOT
TABLE 058. STRYKER CORPORATION: BUSINESS PERFORMANCE
TABLE 059. STRYKER CORPORATION: PRODUCT PORTFOLIO
TABLE 060. STRYKER CORPORATION: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 060. MEDTRONIC PLC: SNAPSHOT
TABLE 061. MEDTRONIC PLC: BUSINESS PERFORMANCE
TABLE 062. MEDTRONIC PLC: PRODUCT PORTFOLIO
TABLE 063. MEDTRONIC PLC: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 063. PRESCIENT SURGICAL INC.: SNAPSHOT
TABLE 064. PRESCIENT SURGICAL INC.: BUSINESS PERFORMANCE
TABLE 065. PRESCIENT SURGICAL INC.: PRODUCT PORTFOLIO
TABLE 066. PRESCIENT SURGICAL INC.: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 066. COVALON TECHNOLOGIES LTD.: SNAPSHOT
TABLE 067. COVALON TECHNOLOGIES LTD.: BUSINESS PERFORMANCE
TABLE 068. COVALON TECHNOLOGIES LTD.: PRODUCT PORTFOLIO
TABLE 069. COVALON TECHNOLOGIES LTD.: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 069. SURGICAL SITE INFECTION PREVENTION LLC: SNAPSHOT
TABLE 070. SURGICAL SITE INFECTION PREVENTION LLC: BUSINESS PERFORMANCE
TABLE 071. SURGICAL SITE INFECTION PREVENTION LLC: PRODUCT PORTFOLIO
TABLE 072. SURGICAL SITE INFECTION PREVENTION LLC: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 072. HARTMANN GROUP: SNAPSHOT
TABLE 073. HARTMANN GROUP: BUSINESS PERFORMANCE
TABLE 074. HARTMANN GROUP: PRODUCT PORTFOLIO
TABLE 075. HARTMANN GROUP: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 075. MÖLNLYCKE HEALTH CARE AB: SNAPSHOT
TABLE 076. MÖLNLYCKE HEALTH CARE AB: BUSINESS PERFORMANCE
TABLE 077. MÖLNLYCKE HEALTH CARE AB: PRODUCT PORTFOLIO
TABLE 078. MÖLNLYCKE HEALTH CARE AB: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 078. BECTON: SNAPSHOT
TABLE 079. BECTON: BUSINESS PERFORMANCE
TABLE 080. BECTON: PRODUCT PORTFOLIO
TABLE 081. BECTON: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 081. DICKINSON AND COMPANY: SNAPSHOT
TABLE 082. DICKINSON AND COMPANY: BUSINESS PERFORMANCE
TABLE 083. DICKINSON AND COMPANY: PRODUCT PORTFOLIO
TABLE 084. DICKINSON AND COMPANY: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 084. OTHER MAJOR PLAYERS: SNAPSHOT
TABLE 085. OTHER MAJOR PLAYERS: BUSINESS PERFORMANCE
TABLE 086. OTHER MAJOR PLAYERS: PRODUCT PORTFOLIO
TABLE 087. OTHER MAJOR PLAYERS: KEY STRATEGIC MOVES AND DEVELOPMENTS

LIST OF FIGURES

FIGURE 001. YEARS CONSIDERED FOR ANALYSIS
FIGURE 002. SCOPE OF THE STUDY
FIGURE 003. SURGICAL SITE INFECTION MARKET OVERVIEW BY REGIONS
FIGURE 004. PORTER'S FIVE FORCES ANALYSIS
FIGURE 005. BARGAINING POWER OF SUPPLIERS
FIGURE 006. COMPETITIVE RIVALRYFIGURE 007. THREAT OF NEW ENTRANTS
FIGURE 008. THREAT OF SUBSTITUTES
FIGURE 009. VALUE CHAIN ANALYSIS
FIGURE 010. PESTLE ANALYSIS
FIGURE 011. SURGICAL SITE INFECTION MARKET OVERVIEW BY PRODUCT
FIGURE 012. WOUND CARE DRESSING MARKET OVERVIEW (2016-2028)
FIGURE 013. ANTIBIOTIC PROPHYLAXIS PRODUCTS MARKET OVERVIEW (2016-2028)
FIGURE 014. ANTISEPTICS AND DISINFECTANTS MARKET OVERVIEW (2016-2028)
FIGURE 015. SURGICAL DRAPERS MARKET OVERVIEW (2016-2028)
FIGURE 016. OTHERS MARKET OVERVIEW (2016-2028)
FIGURE 017. SURGICAL SITE INFECTION MARKET OVERVIEW BY TYPE
FIGURE 018. SUPERFICIAL INCISIONAL INFECTION MARKET OVERVIEW (2016-2028)
FIGURE 019. DEEP INCISIONAL INFECTION MARKET OVERVIEW (2016-2028)
FIGURE 020. SPACE INFECTION MARKET OVERVIEW (2016-2028)
FIGURE 021. SURGICAL SITE INFECTION MARKET OVERVIEW BY PHASE
FIGURE 022. PREOPERATIVE PHASE MARKET OVERVIEW (2016-2028)
FIGURE 023. INTRAOPERATIVE PHASE MARKET OVERVIEW (2016-2028)
FIGURE 024. POSTOPERATIVE PHASE MARKET OVERVIEW (2016-2028)
FIGURE 025. SURGICAL SITE INFECTION MARKET OVERVIEW BY END-USERS
FIGURE 026. HOSPITALS MARKET OVERVIEW (2016-2028)
FIGURE 027. CLINICS MARKET OVERVIEW (2016-2028)
FIGURE 028. AMBULATORY SURGERY CENTERS MARKET OVERVIEW (2016-2028)
FIGURE 029. OTHERS MARKET OVERVIEW (2016-2028)
FIGURE 030. NORTH AMERICA SURGICAL SITE INFECTION MARKET OVERVIEW BY COUNTRY (2016-2028)
FIGURE 031. EUROPE SURGICAL SITE INFECTION MARKET OVERVIEW BY COUNTRY (2016-2028)
FIGURE 032. ASIA PACIFIC SURGICAL SITE INFECTION MARKET OVERVIEW BY COUNTRY (2016-2028)
FIGURE 033. MIDDLE EAST & AFRICA SURGICAL SITE INFECTION MARKET OVERVIEW BY COUNTRY (2016-2028)
FIGURE 034. SOUTH AMERICA SURGICAL SITE INFECTION MARKET OVERVIEW BY COUNTRY (2016-2028)